This is your home base for leading Daya's Ideation stage — where we start with people, not products, and turn unmet needs in women's health into validated, fundable ventures. Everything you need to run the work lives here.
Everything for your first days lives in Drive. Open your onboarding folder first.
Your home base for leading Daya's Ideation stage. A few tools are being updated over the summer — those are flagged. The BUILD Playbook is the source of truth for how we work.
Never be afraid to book a call or ping me on Slack — a Go/No-Go gut-check, a thesis question, an intro, or just to think out loud. That's exactly what I'm here for. 💜 — Malin
Experience-based design to uncover and validate real problems, then decide — with evidence — whether an idea is worth building. Ends in a binary Go / No-Go.
You own thisA committed venture lead co-builds with Daya toward an investable company. This stage is currently the studio's bottleneck.
Backed up right nowVentures that clear Venture Creation join the accelerator cohort with category partners, funding, and go-to-market support.
Your assignment doesn't follow the BUILD Playbook's clean two-month ideation stage — and that's deliberate. You're carrying one live venture (AMY) as a hybrid until the Venture Creation logjam clears. Method and mindset still come from the BUILD Playbook — the single source of truth; scope comes from below.
A precision endocrine–immune diagnostic platform — combining immune/inflammatory markers, endocrine & estrogen-metabolite profiling, genetics and ML to identify which autoimmune patients have hormonally-driven disease. A candidate first indication (Thyroid Eye Disease) is on the table — but the indication is exactly what still needs locking.
You are not working on Pathem or Neblina. They matter to you for one reason only: they're occupying the Venture Creation stage, which is why AMY landed with you as a hybrid. When both clear into Acceleration, the stage frees up and you shift to Phase B. As of mid-July, neither has cleared — so treat Phase A as your reality.
Still to clear: an MVP (dev targeting ~Sep 1), incorporation (Cyprus vs UK), and a signed LOI. Targeting a fall accelerator cohort.
WatchBinding blocker is founders — two not yet locked. Most of the graduation checklist is still open. A supply-side LOI (Nurara) is signed. September target, conditional.
Your standing instruments — these travel with you across every sprint. A few are mid-refresh this summer.
The job is to de-risk a ~€200K investment decision in ~60 days. Finding out early that something won't fly protects the programme and keeps the backlog honest.
Internal enthusiasm, a great workshop, a compelling deck — none of it counts. The only signal that matters is someone external committing time, money, or reputation (an LOI/MOU).
You run a team — Fellows, the BUILD group, external contributors. The work flows through them, not through you: clear tasks, clear owners, clear deadlines.
A 60-day sprint, not a research project. Testing a rough hypothesis beats perfecting it. The faster you find out you're wrong, the faster you find something real.
Validation needs access to the right clinicians, buyers, payers, experts. You start warm — a call booked in days, not weeks.
A venture is killed if any of these is true:
Go → Venture Creation. No-Go → the Idea Backlog, archived with learnings.
Day-to-day coordination, quick updates, decisions in the open. Your default channel inside Daya.
Clinicians, partners, buyers, candidates — anyone outside Daya. Bring your network in here.
All documentation and files live here — dossiers, memos, and the AMY Venture Case.
Two studio rituals you join, and one you own. Times below are the standing slots — confirm the exact invite lands on your calendar in week one.
| Meeting | When | What it is & your part | For you |
|---|---|---|---|
| Start of the Week | Mondays · 12:00 | Whole-studio kickoff for the week ahead. Show up, align, flag where you need help on AMY. |
Join |
| BUILD — Weekly Studio Sync | Tuesdays · 15:00 | The studio sync, mainly focused on the Venture Creation stage. Accelerator and Ideation leads drop in to give quick updates. Give a short AMY / ideation update; listen for pipeline movement (your pivot signal). |
Join · quick update |
| Weekly Ideation Meeting | You set the slot | Yours to run. Invite everyone the BUILD Playbook attaches to Ideation: Fellows Claudia Leitch & Julia Karnysh, plus support leads Jenny Lundkvist (People), Victorine Lancon (Comms), Ute Arndt (Product) and Sophia Pagil (IP). Set sprint goals, tasks, and owners; review evidence; make the calls. |
You run this |
Your own coordinates — for your email signature and booking link.
fiona@fionathwaites.comGo/No-Go sounding board, thesis check, introductions. Also the lead on AMY today. Reach her on Slack, or book a call.
malin@daya.seYour standing invite list for the weekly ideation meeting: the Fellows, plus the support leads the Playbook attaches to Ideation.
Claudia Leitch & Julia Karnysh. Run research, synthesis and outreach; act as early workstream leads; candidates for future venture roles. (They authored the autoimmune finalist analysis.)
Identifies, assesses and pressure-tests potential venture leads; evaluates founder-potential among workshop participants.
jenny@daya.seShapes public and targeted communication around the chosen problem area; runs public calls and campaigns for ideation workshops.
victorine@daya.se · Slack
Brings product and feasibility perspective during Ideation; assists partner and customer outreach.
ute@daya.se · Slack
Performs FTO checks for the Ideation Lead and co-creates the IP & Feasibility note. Your 16 Jul AMY IP sync partner.
sophia@daya.se · Slack
Not all in your stage, but good to have the names. Roles below are from the BUILD Playbook and team profiles.